18.16
Astrana Health Inc stock is traded at $18.16, with a volume of 541.69K.
It is down -4.57% in the last 24 hours and down -37.83% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$19.03
Open:
$19.26
24h Volume:
541.69K
Relative Volume:
0.94
Market Cap:
$910.83M
Revenue:
$2.42B
Net Income/Loss:
$27.64M
P/E Ratio:
35.61
EPS:
0.51
Net Cash Flow:
$121.24M
1W Performance:
-16.35%
1M Performance:
-37.83%
6M Performance:
-37.59%
1Y Performance:
-52.68%
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, UHS, FMS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
18.16 | 954.46M | 2.42B | 27.64M | 121.24M | 0.51 |
|
HCA
Hca Healthcare Inc
|
535.22 | 118.85B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
232.26 | 19.89B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
234.05 | 14.45B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.46 | 13.94B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
214.41 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Zacks Research Downgrades Astrana Health (NASDAQ:ASTH) to Strong Sell - MarketBeat
2 Reasons to Like ASTH (and 1 Not So Much) - Yahoo! Finance Canada
Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 93% Upside Potential In Healthcare - DirectorsTalk Interviews
Astrana Health stock hits 52-week low at 19.99 USD By Investing.com - Investing.com Canada
Astrana Health (NASDAQ:ASTH) Hits New 52-Week LowShould You Sell? - MarketBeat
Astrana Health stock hits 52-week low at 19.99 USD - Investing.com
Diamond Hill Capital Management Inc. Buys 89,733 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health (ASTH): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Three Growth Stocks Insiders Are Eager To Hold - simplywall.st
Healthcare Provider Tech Q3 2025 Earnings Analysis | Sector Performance ReviewNews and Statistics - IndexBox
Healthcare Technology for Providers Stocks Q3 Recap: Benchmarking Astrana Health (NASDAQ:ASTH) - Barchart.com
BTIG Research Has Lowered Expectations for Astrana Health (NASDAQ:ASTH) Stock Price - MarketBeat
6 Analysts Assess Astrana Health: What You Need To Know - Benzinga
Optimism Around Astrana Health (NASDAQ:ASTH) Delivering New Earnings Growth May Be Shrinking as Stock Declines 16% This Past Week - 富途牛牛
Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
A Look At Astrana Health's Valuation After CMS Medicare Advantage Payment Proposal - Sahm
Hussman Strategic Advisors Inc. Sells 105,000 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst - Benzinga
ASTH SEC FilingsAstrana Health 10-K, 10-Q, 8-K Forms - Stock Titan
Layoff Watch: Is Clearwater Paper Corporations growth already priced inStock Surge & Weekly Return Optimization Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Astrana Health (NASDAQ:ASTH) Shares Gap DownTime to Sell? - MarketBeat
Astrana Health Inc. (ASTH) Investor Outlook: Unpacking The 35.52% Upside Potential - DirectorsTalk Interviews
Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call - Yahoo Finance
RSI Check: Should I set a stop loss on Astrana Health IncJuly 2025 Gainers & Consistent Return Strategy Ideas - baoquankhu1.vn
Gap Down: Is Astrana Health Inc on track to beat earnings2025 Price Action Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Recap Report: Is Astrana Health Inc impacted by rising ratesJuly 2025 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn
Astrana Health Inc. (ASTH) Stock Analysis: Exploring Its 36.88% Upside Potential - DirectorsTalk Interviews
Astrana Health initiated with a buy at Needham - MSN
SG Americas Securities LLC Acquires New Shares in Astrana Health, Inc. $ASTH - MarketBeat
Campbell & CO Investment Adviser LLC Takes $1.15 Million Position in Astrana Health, Inc. $ASTH - MarketBeat
Trend Report: Will Astrana Health Inc face regulatory challenges2025 Sector Review & Risk Controlled Stock Alerts - baoquankhu1.vn
Analysts Are Bullish on These Healthcare Stocks: Palvella Therapeutics (PVLA), Nurix Therapeutics (NRIX) - The Globe and Mail
Insider Activity Update: David Schmidt Executes Options Exercise, Resulting In $431K At Astrana Health - Benzinga
Astrana Health (NASDAQ:ASTH) Trading Up 7.9%Should You Buy? - MarketBeat
Will Astrana Health’s 16-Market Expansion Refocus Its Value-Based Care Strategy Narrative (ASTH)? - simplywall.st
Astrana Health (NASDAQ:ASTH) Upgraded by Zacks Research to Hold Rating - MarketBeat
Does Astrana’s 16-Market Value-Based Care Push Reframe the Bull Case for Astrana Health (ASTH)? - Yahoo Finance
A Look At Astrana Health’s Valuation As It Updates Investor Presentation For National Platform Expansion - Yahoo Finance
Astrana Health (NASDAQ:ASTH) Trading Down 6.3%Should You Sell? - MarketBeat
Astrana Health Touts Delegated Risk “Single Payer” Model, Prospect Synergies, Reiterates 2025 Guide - Yahoo Finance
Astrana Health Updates Investor Presentation Highlighting National Expansion - TipRanks
CMS new accountable care model seen benefitting value-based care providers - MSN
What downside risks could hit Astrana Health Inc. (3AM) stockQuarterly Earnings Summary & Community Verified Swing Trade Signals - Улправда
Will Astrana Health Inc. (3AM) stock boost dividends furtherMarket Sentiment Indicators & Free Extraordinary Earning Power - ulpravda.ru
Revenue per share of Astrana Health Inc. – MUN:3AM - TradingView — Track All Markets
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 37.47% Potential Upside Awaits Investors - DirectorsTalk Interviews
Great Week for Astrana Health, Inc. (NASDAQ:ASTH) Institutional Investors After Losing 12% Over the Previous Year - 富途牛牛
J.P. Morgan healthcare event talk from Astrana Health will stream online - Stock Titan
Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Astrana Health (NASDAQ:ASTH) Nasdaq Futures Frame Digital Care Delivery - Kalkine Media
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):